Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in PEPG — PepGen Inc.

CIK 886982 NEW YORK, NY
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$302,598
+$57,183 QoQ
Shares Held
168,110
+21.2% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 72 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PEPG ranks #305 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in PEPG

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $302,598 168,110
2026-03-31 $245,415 138,653
2025-12-31 $1,572,933 241,618
2025-06-30 $78,369 70,603
2025-03-31 $56,537 40,240
2024-12-31 $372,723 98,344
2024-09-30 $502,757 58,802
2024-03-31 $194,231 13,213
2023-12-31 $96,260 14,156
2023-06-30 $123,595 13,825
2023-03-31 $391,898 32,044
2022-12-31 $147,417 11,026